What is LIPO's health score?

LIPELLA PHARMACEUTICALS INC. (LIPO) has a TradeApes health score of 34 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LIPO's estimated fair value?

Based on our 5-year discounted cash flow model, LIPELLA PHARMACEUTICALS INC.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is LIPO undervalued or overvalued?

Our model currently rates LIPO as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LIPO... Refresh in a moment for the full analysis.

LIPELLA PHARMACEUTICALS INC. (LIPO)

Healthcare Inconclusive inconclusive weak

$0.08

Updated: 2026-06-05

TradeApes Score

Financial Strength

35 Weak

Operating Trend

10 Stressed

Relative Value

60 Healthy

Capital Allocation

30 Weak

Risk

35 Weak

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.